Medications for Telangiectasia
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Telangiectasia.
Found 2 Approved Drugs for Telangiectasia
Polidocanol
Brand Names
Varithena, Asclera
Polidocanol
Brand Names
Varithena, Asclera
Form: Injection, Kit
Method of administration: Intravenous
FDA approval date: June 01, 2010
Classification: Sclerosing Agent
Asclera ® (polidocanol) is indicated to sclerose uncomplicated spider veins (varicose veins ≤1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity. Asclera has not been studied in varicose veins more than 3 mm in diameter. Asclera (polidocanol) is a sclerosing agent indicated to sclerose uncomplicated spider veins (varicose veins ≤1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity. Asclera has not been studied in varicose veins more than 3mm in diameter. ( 1 )
Encelto
Generic Name
Revakinagene Taroretcel-Lwey
Encelto
Generic Name
Revakinagene Taroretcel-Lwey
Form: Implant
Method of administration: Intravitreal
FDA approval date: March 12, 2025
ENCELTO is indicated for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel). ENCELTO is an allogeneic encapsulated cell-based gene therapy indicated for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel).
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances